Neonatal Alcohol‐Induced Region‐Dependent Changes in Rat Brain Neurochemistry Measured by High‐Resolution Magnetic Resonance Spectroscopy

Departments of Psychology, Wayne State University School of Medicine, Detroit, Michigan, USA.
Alcoholism Clinical and Experimental Research (Impact Factor: 3.21). 10/2008; 32(10):1697-707. DOI: 10.1111/j.1530-0277.2008.00747.x
Source: PubMed


Maternal drinking during pregnancy can lead to a range of deleterious outcomes in the developing offspring that have been collectively termed fetal alcohol spectrum disorders (FASDs). There is interest and recognized value in using non-invasive neuroimaging techniques such as magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) to characterize, respectively, structural and biochemical alterations in individuals with FASDs. To date, however, results with MRS have been inconsistent regarding the degree and/or nature of abnormalities.
High-resolution magic angle spinning (HR-MAS) proton ((1)H) MRS is an ex vivo neuroimaging technique that can acquire spectra in small punches of intact tissue, providing clinically relevant neurochemical information about discrete brain regions. In this study, HR-MAS (1)H MRS was used to examine regional neurochemistry in frontal cortex, striatum, hippocampus, and cerebellum of young rats previously exposed to ethanol as neonates. Key neurochemicals of interest included N-acetyl-aspartate (NAA), glutamate, GABA, glutamine, creatine, choline and myo-inositol.
Daily neonatal alcohol exposure from postnatal day 4 (PN4) through PN9 significantly reduced levels of NAA and taurine in the cerebellum and striatum, and induced sex-dependent reductions in cerebellar glutamate when measured on PN16. In addition, myo-inositol was significantly increased in cerebellum. The frontal cortex and hippocampus were virtually unaffected by this neonatal alcohol exposure.
Results of this research may have implications for understanding the underlying neurobiology associated with FASDs and aid in testing treatments in the future. Ongoing studies are assessing the developmental persistence of and/or maturational recovery from these changes.

Download full-text


Available from: John H Hannigan
  • [Show abstract] [Hide abstract]
    ABSTRACT: Today, structure elucidation of complex organic molecules relies heavily on the application of proton-detected heteronuclear NMR techniques. Among these techniques, the HMBC experiment is one of the most useful 2D NMR methods. Carbon–proton HMBC experiments allow the assignment of structural frag- ments through correlations between protons and carbons separated by more than one bond, usually two or three bonds via small 1H–13C couplings, usually 2JCH and 3JCH, but also over longer bond chains, n > 3JCH, especially in conjugated systems. In the decade preceding this review, several significant extensions to the basic HMBC experiment have been made. The main directions of develop- ments were widening the range of accessible long-range J-coupling constants, improving sensitivity, refining resolution, suppressing one-bond correlations and accurately determining long-range coupling constants. In addition, increasing the efficiency of multi-dimensional NMR techniques, an important contempo- rary trend in NMR, has also had its impact on HMBC, with multiplex approaches and parallel acquisition techniques emerging. Structure elucidation and signal assignment of proton-deficient molecules like condensed aromatics has bene- fited most substantially from the new possibilities for a detailed analysis of long- range correlations. In this review, we summarize the basic variants of HMBC and discuss recent developments related to the technique, focusing on develop- ments of new pulse sequences and processing protocols.
    No preview · Article · Jan 2010 · Annual Reports on NMR Spectroscopy
  • [Show abstract] [Hide abstract]
    ABSTRACT: Risk-taking behaviors involve increased motor activity and reduced anxiety in humans. Total sleep deprivation (SD) in animals produces a similar change in motor and fear behaviors. Investigators studied region-specific brain levels of glutamate in rats after TSD, an animal model of risk-taking behavior. We investigated the effects of sleep deprivation on these behaviors and associated levels of brain glutamate. Compared to the controls, the sleep-deprived rats spent a significantly greater percentage of time in the open arms of the elevated plus maze (EPM), demonstrating reduced fear-like and increased risk-taking behaviors. Additionally, sleep deprivation was associated with a significant increase in glutamate levels in the hippocampus and thalamus. An inverse relationship between glutamate in the medial prefrontal cortex and risk taking in the EPM and a positive association between the ratio of glutamate in the hippocampus to medial prefrontal cortex and risk taking was revealed. The role of sleep deprivation-induced changes in brain glutamate and its relationship to anxiety, fear, and posttraumatic stress disorder (PTSD) is discussed.
    No preview · Article · Mar 2010 · Physiology & Behavior
  • [Show abstract] [Hide abstract]
    ABSTRACT: In an effort to alter the levels of neurochemicals involved in excitotoxicity, we treated mice with methionine sulfoximine (MSO), an inhibitor of glutamine synthetase. Since glutamate toxicity has been proposed as a mechanism for the degeneration of motor neurons in a variety of neurodegenerative diseases, we tested the effects of MSO on the transgenic mouse that overexpresses the mutant human SOD1(G93A) gene, an animal model for the primary inherited form of the human neurodegenerative disease amyotrophic lateral sclerosis (ALS). This treatment in vivo reduced glutamine synthetase activity measured in vitro by 85%. Proton magnetic resonance spectroscopy, with magic angle spinning of intact samples of brain tissue, showed that MSO treatment reduced brain levels of glutamine by 60% and of glutamate by 30% in both the motor cortex and the anterior striatum, while also affecting levels of GABA and glutathione. Kaplan-Meyer survival analysis revealed that MSO treatment significantly extended the lifespan of these mice by 8% (p<0.01). These results show that in the SOD1(G93A) model of neurodegenerative diseases, the concentration of brain glutamate (determined with (1)H-MRS) can be lowered by inhibiting in vivo the synthesis of glutamine with non-toxic doses of MSO.
    No preview · Article · Mar 2010 · Journal of the neurological sciences
Show more